Masimo (NASDAQ:MASI) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $2.92 from $2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.91. The company issued revenue guidance of $854 million from $850 million, compared to the consensus revenue estimate of $851.38 million.Masimo also updated its FY 2018 guidance to $2.92-2.92 EPS.
Several research analysts have recently commented on MASI shares. Stifel Nicolaus lifted their price objective on Masimo from $112.00 to $145.00 and gave the stock a buy rating in a report on Tuesday, October 2nd. Needham & Company LLC started coverage on Masimo in a report on Friday, September 14th. They issued a buy rating on the stock. BidaskClub upgraded Masimo from a buy rating to a strong-buy rating in a report on Friday, August 17th. Finally, Zacks Investment Research downgraded Masimo from a buy rating to a hold rating in a report on Wednesday, August 1st. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $109.20.
Shares of MASI traded up $0.03 during trading hours on Wednesday, hitting $115.60. The company had a trading volume of 613,541 shares, compared to its average volume of 517,413. The company has a market cap of $5.88 billion, a P/E ratio of 47.18, a P/E/G ratio of 2.64 and a beta of 1.01. Masimo has a 52-week low of $80.69 and a 52-week high of $126.89.
In related news, CEO Joe E. Kiani sold 29,273 shares of the business’s stock in a transaction dated Thursday, August 2nd. The stock was sold at an average price of $109.08, for a total transaction of $3,193,098.84. Following the transaction, the chief executive officer now owns 168,514 shares in the company, valued at approximately $18,381,507.12. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ramshorst David J. Van sold 1,325 shares of the business’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $125.00, for a total value of $165,625.00. Following the transaction, the insider now owns 2,325 shares in the company, valued at approximately $290,625. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 763,380 shares of company stock worth $90,518,456. 12.60% of the stock is owned by company insiders.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Recommended Story: Risk Tolerance
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.